Analysts: Salesforce Outlook Remains Positive and 3 More Research Notes to Check Out
Salesforce.com (NYSE:CRM): Wunderlich has raised its price target on Salesforce, to $65 from $51.75, citing a more positive outlook following the company’s acquisition of ExactTarget. The firm keeps a Buy rating on the stock.
Morgan Stanley (NYSE:MS): Oppenheimer has brought its rating of Morgan Stanley from Outperform to Perform, citing valuation concerns with the stock near the company’s tangible book value.
Monsanto (NYSE:MON): Morgan Stanley said that Argentina’s Agricultural minister implied that China has approved Monsanto’s Intacta soybeans for import, which the firm believes is an important part of its Overweight thesis and could add $2 in incremental earnings.
Occidental Petroleum (NYSE:OXY): Bank of America/Merrill Lynch believes there is zero chance that Occidental will not split up, and that an IPO of California looks likely, and in addition, monetization of the Middle East will be through an sale or an IPO. The firm said reports that the company will not pursue a “material” buyback are incorrect and that a break-up could be worth $150 per share. Shares are Outperform rated with a $150 price target.